Auto-generated event page
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
MADRID and CAMBRIDGE, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global lead...
Score 41
low confidence
1 source posts
Updated Feb 27, 2026, 5:42 PM UTC